The technological and pharmacological advances lead to an increase in the number of molecules for R&D that are challenging and difficult to manufacture. To improve clinical success, pharma and biotech companies are seeking innovative ways to accelerate progress and reduce scientific, economic, and delivery risks.
Transformative innovation in drug development
BackgroundThe technological and pharmacological advances lead to an increase in the number of molecules for R&D that are challenging and difficult to manufacture. To improve clinical success, pharma and biotech companies are seeking innovative ways to accelerate progress and reduce scientific, economic, and delivery risks.
AI specialist Quinten Health bags €14m financing
Latest NewsQuinten Group’s French healthcare arm Quinten Health has closed a financing round to advance disease modeling platforms and virtual twins in real-world.
Bavarian Nordic expands vaccine contract by $234m
Latest NewsBavarian Nordic A/S has expand its smallpox contract signed with the Canadian PHAC in June from $56m to $470m including $180m in contract options.
Mimetas: New Chair of the Board
AppointmentsLeiden-based Mimetas, specialist in organ-on-chip-based disease models for drug discovery and development, has appointed Dhaval Patel (UCB, Belgium) as Chair of its Board of Directors.
Why vaccine developers need a Charged Aerosol Detector: Reason 3
Sponsored PublicationsWhy are so many vaccine developers choosing Thermo Scientific Charged Aerosol Detection (CAD)? Hear the third very good reasons why CAD was used for analysis of lipid nanoparticles in approved mRNA vaccines.
Genfit swallows Versantis in €105m deal
Latest NewsThrough the acquisition of Versantis for €40m upfront and further €65m in milestones, Genfit SA has added three clinical and preclinical candidates to its liver drug portfolio.
Food specialist Standing Ovation SA raises €12m
Latest NewsFoodtech startup Standing Ovation SA has closed an oversubscribed €12m Series A financing round led by Astanor Ventures.
Lytix Biopharma: CBO-Position new filled
AppointmentsOslo-based Lytix Biopharma has a new Chief Business Officer. Stephen Worsley has started at the Norwegian immune-oncology company at the beginning of September.
HeartBeat.bio inks partnership with Molecular Devices
Latest NewsHeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput drug discovery screening
Mobile app recognises COVID-19 infection
Latest NewsDutch researchers report they could detect a COVID-19 infection with better sensitivity than antigen tests by a mobile app that uses AI to analyse voice recordings.